Click image to view original image
| Cjc-1295 Without Dac CAS: 863288-34-0 Formula: C152H252N44O42 Molecular weight: 3367.2 purity: > 98.0% Appearance: White powder Related substance: Total Impurities(%) < 2.0% Acetate content: < 15.0% Bacterial Endotoxins: <5 IU/mg As we know, CJC-1295 is a tetrasubstituted 30-amino acid peptide hormone, primarily functioning as a hormone releasing hormone (GHRH) analog. Clinical Research was first conducted for CJC-1295 during the mid-2000s. The objective of the peptide was to treat visceral fat deposits in obese AIDS patients, as increased levels of exogenous are presumed to increase lipolysis (fat loss). The clinical research was ultimately successful for most research subjects Another very positive benefit of CJC-1295 is its ability to promote slow wave sleep. Slow wave sleep is also known as deep sleep and is the portion of sleep responsible for the highest level of muscle growth and memory retention. SWS is decreased significantly in older adults and also with people who tend to exercise later in the evening. Clinical studies have shown that a once-daily administration of CJC-1295, a long-acting hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH can induce significantly deeper sleep in a mouse. |
